Washington [US], June 12 (ANI): A new study has found that a patient can undergo T cell therapy designed to target cancerous tumours, the patient's entire immune system must be destroyed with chemotherapy or radiation.
Washington [US], June 9 (ANI): According to a study by the University of California-Los Angeles Health Science, before a patient can undergo T cell therapy designed to target cancerous tumours, the patient's entire immune system must be destroyed with chemotherapy or radiation.
New Jersey [US], June 6 (ANI): According to new research, Neuroblastoma is paediatric cancer that arises from immature nerve cells. Approximately half of the children with neuroblastoma have a type that suggests a high risk of recurrence. Patients with this high-risk neuroblastoma may benefi
Washington [US], June 5 (ANI): Circulating tumor DNA (ctDNA) thats is a genetic material shed from tumors into the bloodstream can identify stage II colon cancer patients who can most benefit from chemotherapy following surgery and spare other patients the need for this form of treatment, ac
Washington [US], May 31 (ANI): According to a new study by The American College of Cardiology, older breast cancer survivors with cardiometabolic risk factors who restricted food consumption to eight hours during the workday, followed by 16 hours of fasting, had a decreased risk of CVD after
New Delhi [India], April 30 (ANI): The Central Bureau of Investigation (CBI) on Friday registered a case against a senior Oncologist for alleged medical negligence leading to the death of a Bahraini national.
Washington [US], April 24 (ANI): Over the past few decades treatments for ovarian cancer have barely changed. Currently, surgery and chemotherapy are the most common therapeutic approaches for it.
Washington [US], April 18 (ANI): Treatments for ovarian cancer have changed little over the past few decades, with surgery and chemotherapy being the most common therapeutic approaches.
Washington [US], March 20 (ANI): Do you know malaria drugs work against some cancers? According to a new study, the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in head and neck cancers and restores tumour-killing effects of cisp
Washington [US], March 15 (ANI): A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in head and neck cancers and restores tumour-killing effects of cisplatin in animal models.
Washington [US], March 13 (ANI): Even though nanoparticles, which are tiny structures, can be used to carry substances to certain parts of the body, hence offering hope for improving cancer therapeutics, the survival benefits of clinically approved nanomedicines are often modest in compariso
Denver (Colorado) [US], February 20 (ANI): HIV (human immunodeficiency virus) a virus that attacks the body's immune system has been known to have no cure. However, a patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukaemia has been free of the